Achieve Life Sciences
ACHV
23 hedge funds and large institutions have $1.86M invested in Achieve Life Sciences in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 4 closing their positions.
200% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 4
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
53% more funds holding
Funds holding: 15 → 23 (+8)
44% more capital invested
Capital invested by funds: $1.3M → $1.86M (+$567K)
14.38% less ownership
Funds ownership: 26.91% → 12.53% (-14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$525K |
| 2 |
Renaissance Technologies
New York
|
+$356K |
| 3 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$196K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$117K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$101K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$234K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.16K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$949 |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$127 |
ACHV Hedge Fund Activity: Q3 2018 in Review
23 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2018, worth a combined $1.86M — up 44% from $1.3M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ACHV positions and 4 closed out — a net gain of 8 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Sio Capital Management, opening a new position worth an estimated $525K. The largest seller was Armistice Capital, exiting entirely with an estimated $234K sold.
- 23 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2018, up from 15 in Q2 2018.
- Funds reported $1.86M of Achieve Life Sciences stock for Q3 2018, up 44% quarter-over-quarter.
- 12 funds opened new Achieve Life Sciences positions in Q3 2018 and 4 closed out, a net change of +8 holders.
- The largest Achieve Life Sciences buyer in Q3 2018 was Sio Capital Management, an estimated $525K added.
- The largest Achieve Life Sciences seller in Q3 2018 was Armistice Capital, an estimated $234K sold.
Based on aggregated 13F filings for Q3 2018.